- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Advanced Parkinson Disease
- Meeting Date: November 2024
- Public Summary Document (PSD) November 2024 PBAC Meeting - (PDF 566KB)
- Public Summary Document (PSD) November 2024 PBAC Meeting - (Word 115KB)
Foslevodopa with foscarbidopa – November 2024
Foslevodopa with Foscarbidopa; Solution for subcutaneous infusion foslevodopa 2400 mg with foscarbidopa 120 mg in 10 mL; Vyalev®
Last updated
30 May 2025
